Clinical Trials Directory

Trials / Completed

CompletedNCT05205044

Evaluation of Apelin-13 and Apelin-36 in Women With Recurrent Pregnancy Loss

Evaluation of Apelin-13 and Apelin-36 Concentrations in Women With Primary Unexplained Recurrent Pregnancy Loss

Status
Completed
Phase
Study type
Observational
Enrollment
88 (actual)
Sponsor
Ain Shams University · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers

Summary

Lower Apelin levels are associated with hypertensive disorders with pregnancy, yet no studies investigated its levels in recurrent pregnancy loss

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTApelin-13, Apelin-36Serum levels of Apelin-13 and Apelin-36

Timeline

Start date
2022-01-23
Primary completion
2023-01-30
Completion
2023-01-30
First posted
2022-01-24
Last updated
2023-02-14

Locations

2 sites across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05205044. Inclusion in this directory is not an endorsement.